Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities

NCT01101035 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01101035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01101035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
April 23, 2010
Completion date
July 18, 2017
Enrollment
6,198 (actual)
Sites
203

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease